CVS Health Corp vs Trump Media and Technology Group Corp — how do they compare? CVS Health Corp trades at $94.81 (market cap $119.58B), while Trump Media and Technology Group Corp trades at $8.37 (market cap $2.48B). The key difference: CVS Health Corp is far larger — about 48.2× Trump Media and Technology Group Corp's market cap, and CVS Health Corp pays a 2.84% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals.
| CVS | DJT | |
|---|---|---|
Market Cap | $119.58B | $2.48B |
Sector | Health | Media |
52-Week High | $110.60 | $18.50 |
52-Week Low | $65.51 | $7.06 |
Enterprise Value | $181.93B | $2.54B |
Dividend Yield | 2.84% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $94.12, down 1.62% today, but maintains strong analyst support with 33 buy ratings and a $115.90 consensus price target. The company delivered three consecutive earnings beats in 2026, with Q2 EPS of $2.58 beating expectations by 38%. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, while fundamentals reveal solid revenue growth to $402.07B in 2025 despite margin compression.
CVS presents a compelling value opportunity with attractive valuation ratios (P/S: 0.29, P/B: 1.5) and strong institutional confidence. Near-term catalysts include continued Aetna recovery and healthcare services expansion, though risks include 2027 PBM pressures and margin volatility. The stock offers 23% upside to analyst targets with defensive healthcare positioning.
DJT stock trades at $8.38, down 10.81% in the last 24 hours, reflecting a bearish technical signal. The company reported Q2 2026 revenue of $1.67 million, up 89% year-over-year, but net losses widened to $238.1 million due to digital asset declines. The price-to-sales ratio of 547.62 indicates an extremely high valuation relative to minimal revenue, while negative profitability metrics and substantial cash burn persist.
The outlook remains highly speculative with significant risks from unsustainable losses and volatile digital asset holdings. Investment appeal is limited to high-risk tolerance given the lack of profitability and bearish analyst sentiment. Key catalysts include future revenue growth from new products like the Truth API, but current fundamentals do not support the valuation.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →